Atlas Trials

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Clinical trial NCT03206255 · COMPLETED

Trial details

NCT number
NCT03206255
Sponsor
Jun Zhang
Status
COMPLETED
Study type
OBSERVATIONAL
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial NeoplasiaVulvar Intraepithelial NeoplasiaPersistent Infection
Start date
2017-07-01
Primary completion
2018-08-15
Enrollment
940

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.